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The use of unsedated transnasal esophagogastroduodenoscopy (UT-EGD) is a milestone in gastrointes-
tinal endoscopy. Although the image quality, suction, air insufﬂation, and lens washing in UT-EGD have
been reported to be inferior to those in conventional peroral EGD (P-EGD), the former procedure is
associated with reduced gag reﬂex and is better tolerated than the latter. Several large studies have
shown that transnasal endoscopy is safe, well tolerated, and less risky than P-EGD, which requires
sedation in most western countries. Moreover, UT-EGD induces less sympathetic stimulation and less
oxygen desaturation compared with P-EGD. Use of an ultrathin endoscopy, an alternative choice to
endoscopic retrograde cholangiography, is helpful in patients with gastrointestinal stenosis and is a
convenient method for postpyloric feeding tube placement. However, nasal anesthetic methods, tech-
niques of scope insertion and withdrawal from the delicate nasal cavity, and therapeutic applications
may be difﬁcult to learn without proper training, even for an experienced endoscopist.
Copyright  2013, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Ultrathinendoscopeswere initially developed in the1970s foruse
inpediatricpatients [1]. In1994, Shaker [2]ﬁrst reported theuseof an
ultrathin endoscope to perform unsedated transnasal esophagogas-
troduodenoscopy (UT-EGD) in adults, a milestone in gastrointestinal
endoscopy. UT-EGD has been used extensively in Japan since 2002,
when ultrathin videoscopes became available there. Unlike the
United States, Canada, and some European countries (such as France,
Italy, and The Netherlands) have been using UT-EGD for many years.
In theUnitedStates, upperendoscopy is performedunder sedation to
reduce patient discomfort. However, sedation is the main cause of
morbidity andmortality during endoscopy. UT-EGD does not require
sedation, and there is strong evidence conﬁrming its safety and cost
effectiveness [3,4]. Although it is not difﬁcult for an endoscopist
competent in peroral EGD (P-EGD) to perform UT-EGD, special
techniques in transnasal anesthesia, nasal insertion, andwithdrawal
of a scope from nasal cavity require speciﬁc training. The aim of this
review is to update medical/paramedical staff, clinicians, and gas-
troenterologists on the advantages and disadvantages of UT-EGD.ogy, Department of Internal
, Chung-Yang Road, Hualien,
ddhist Compassion Relief Tzu Chi2. Technical characteristics
2.1. Transnasal endoscopy room and endoscopes
Transnasal endoscopy can be performed without sedation in a
quiet, warm place. A transnasal endoscopy room that was set up in
the Buddhist Tzu Chi General Hospital has been modiﬁed to help
relax unsedated patients (Fig. 1). Unsedated UT-EGD can be applied
via either the oral or the transnasal route. Currently there are three
brands of transnasal endoscopes with special image features: nar-
row band imaging (NBI, Olympus Corporation, Tokyo, Japan),
formerly “Fujinon intelligent chromo endoscopy”, now known as
“ﬂexible spectral imaging color enhancement” (FICE, Fujinon Cor-
poration, Tokyo, Japan), and iSCAN (Pentax Corporation, Tokyo,
Japan). Characteristics and sizes of these typical transnasal endo-
scopes are shown in Table 1 and Fig. 2. UT-EGD is suggested as an
alternative to P-EGD for some uncooperative patients or those with
“endoscophobia.”
2.2. Patency test
2.2.1. Sniff test
The sniff test has been applied widely since the report of Shaker
in 1994 [2]. The technique is very simple but regarded as a sub-
jective test. For the selection of the more patent nostril, a patient isFoundation. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Design of the transnasal endoscopy room at the Buddhist Tzu Chi General Hospital, Hualien, Taiwan, with a relaxed, warm, welcoming atmosphere. (A) Initial design of the
room closed by two sliding door curtains; (B) design modiﬁcation, considering patient’s privacy, with internally controlled electronic doors with welcoming, “Mickey Mouse”
windows and warm lighting; (C) initial ceiling design of the room, similar to that of other conventional endoscopy rooms; (D) improvement in the “cold,” sterile atmosphere using
new ceiling boards exhibiting a blue sky and white clouds, thereby creating a calm environment.
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sealed by the examiner’s index ﬁnger; the nostril through which air
passes more easily is chosen. A more objective method such as a
meatuscopy should be used for selecting the most patent meatus
for anesthesia and endoscopic insertion.
2.2.2. Plastic cotton-tipped applicator priming test
As described in our previous study [5], a cotton-tipped applicator
priming test helps determine the following: (1) right or left nostril;
(2) inferior nasal meatus (INM) ormiddle nasalmeatus (MNM); and
(3) theneed for epinephrinedecongestion. Two sterile, 3 inch1/10Table 1
Representative transnasal endoscopes.
Model Angulation
(degree)
Field of
view
(degree)
Shaft
diameter
(mm)
Channel
diameter
(mm)
Working
length
(mm)
Special
feature
Olympus Both types:
GIF-XP180N 210[/90Y 120 5.5 2 1100 NBI
GIF-XP260N 100)/100/ 120 5.5 (5.0)a 2 1100 NBI
Fujinon Both types:
EG-530N 210[/90Y 120 5.9 2 1100 FICE
EG-530NW 100)/100/ 140 5.9 2 1100 FICE/BL
Pentax Both types:
EG 1690K 210[/120Y 120 5.4 2 1100 iSCAN
EG 1870K 120)/120/ 140 6 2 1050 iSCAN
BL¼ bright light; FICE¼ ﬂexible spectral imaging color enhancement; NBI¼ narrow
band image; [/Y ¼ up/down angulation;)/ ¼ left/right angulation.
a A 5.5-mm insertion tube with a 5-mm-diameter distal end.inch, plastic cotton-tipped applicators, pretreated with a minimal
amount of 2% viscous lidocaine plus 4% liquid lidocaine, can be
applied gently in parallel to test for the most patent meatus. TwoFig. 2. Two commonly used transnasal endoscopes. Shaft diameters of a (A) pencil, (B)
Olympus GIF-XP260N endoscope, and (C) Fujinon EG-530N endoscope are 6 mm,
5.5 mm, and 5.9 mm, respectively. The Olympus endoscope has a tapered distal end
(5 mm in diameter, compared with the 5.5-mm-diameter insertion tube).
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tipped up by 5 for the MNM. Successful passage of the two appli-
cators gives a good hint of the subsequent ease or difﬁculty in
anesthetizing and decongesting a meatus for endoscope insertion.2.3. Nasal anesthesia
Although a pharyngeal reﬂex is inevitable, it can be reduced by
adopting an upright position, drinking water, or breathing deeply;
therefore, pharyngeal anesthesia is still recommended. In brief, we
found that tolerability to UT-EGD is dependent on different
techniques of nasal anesthesia in the following order:
pledgetting > spray > cotton-tipped applicator methods [6].
2.3.1. Cotton-tippled applicator method (Shaker technique)
Cotton-tipped applicator nasal anesthesia (CTNA) was described
by Shaker in 1994 [2]. With the patient in a sitting position, the
more patent nostril is selected after the patient inhales through
only one nostril with the other being sealed by the examiner’s in-
dex ﬁnger. In patients with a narrow nasal vault, one 2-second puff
of 0.05% epinephrine is applied to each of the anterior nares by an
atomizer to enlarge the anterior nasal cavity. About 2 mL of 2%
lidocaine gel is applied to the selected INM or MNM using a cotton-
tippled applicator of a suitable size.
2.3.2. Three-step decongestive anesthesia (Miyawaki technique)
In 1998, Miyawaki (Izumo Central Clinic, Shimane, Japan)
developed a three-step premedication method. This method in-
cludes the following procedures: (1) administration of 0.05% oxy-
metazoline to the anterior nares via an atomizer; (2) direct syringe
injection of 4 mL liquid lidocaine (2%) into the patient-selected
nostril (sniff test); and (3) insertion of, ﬁrst, a thick, followed by a
thin (6 mm and 4 mm diameters, respectively) 12-cm truncated
distal end of a Foley catheter sprayed with 8% liquid lidocaine into
the selected nasal meatus [5].
2.3.3. Anesthetic-free method (Barberani technique)
UT-EGD is very popular in Italy. Barberani et al [7] reported their
UT-EGD experience in which no premedication was used for nasal
anesthesia. In fact, comparative acoustic rhinometry has shown
that the nasal minimal cross-sectional area is smaller in Asians than
inwhites and blacks [5]. Therefore, when examining Asian patients,
endoscopists should be careful in the application and selection of
an appropriate nasal anesthesia.
2.3.4. Lidocaine spray
The use of a spray prior to UT-EGDwas ﬁrst described in 2006 [8].
A high concentration of lidocainenot only causes a tingling sensationTable 2
Comparison of commonly used unsedated transnasal endoscopic techniques and anesth
Method Shaker [2] Miyawa
Technique Cotton-tipped applicator Three-s
Body position Sitting LLD
Scopolamine injection yes Nil
Pronase Nil Yes
Nasal decongestion Bilateral (optional)
0.05% epinephrine
Bilatera
0.05% o
Nasal anesthetics 2% Lido. jelly 4% Lido
Oral spray 8e10% Lido. Nil
Selected nasal meatus Inferior or middle Middle
Anesthetic time (min) 3e6 20
Swallowing during insertion Yes Yes
Lido. ¼ liquid lidocaine; LLD ¼ left lateral decubitus; oxymet. ¼ oxymetazoline.in the nose and eyes, but may also result in intoxication, with
symptoms such as lightheadedness, dizziness, or even seizures. Use
of an 8% or a 10% lidocaine spray is very common inmost endoscopy
rooms. Direct spray of 8% or 10% lidocaine is not only irritating, but
mayalso induce complications. Lin et al [9] reporteda caseofpossible
lidocaine intoxication from 8% lidocaine sprays into the nasal cavity.
2.3.5. Endoscopic-guided nasal anesthesia
A strong grasp of nasal anesthetic skills is the key to a gastro-
enterologist’s successful performance of awell-tolerated transnasal
endoscopic procedure. Our group compared a novel endoscopic-
guided nasal anesthesia with the conventional CTNA [5]. A spray
(known as endoscopic-guided aerosolized spray) is used for the
endoscopic-guided nasal anesthesia, which is better tolerated,
causes less epistaxis, improves visualization capacity, and reduces
procedure time compared to that in case of CTNA [5].
2.3.6. Cotton-tipped applicator primed gauze pledgetting
We later invented another method, cotton-tipped applicator
primed gauze pledgetting, and compared it with endoscopic-
guided aerosolized spray. The cotton-tipped applicator primed
gauze pledgetting was found to be better tolerated and to elicit less
unpleasant taste, fewer gagging episodes, and less throat pain after
UT-EGD [6]. A detailed comparison of different nasal anesthetic
techniques is given in Table 2 [2,5e7].2.4. Patient position
Although the standard left lateral decubitus position is most
commonly used, the upright sitting position is recommended to
reduce the gag reﬂex. However, we found that remaining in an
upright position is suboptimal for transnasal gastroscopy [10]. In
case an endoscope is located in the antrum, the antrum is more
extended when a patient shifts from the upright position to the left
lateral decubitus position [11].3. Feasibility
Successful transnasal insertion depends on the following fac-
tors: (1) age and gender; (2) size of the nasal meatus and tubinates;
(3) scope size; (4) anesthetic method; and (5) endoscopic proce-
dure. UT-EGD was found to exhibit a success rate of 88% in 33
volunteers [12]. Dumortier et al [13] reported that UT-EGD was
performed in 1100 consecutive patients using a Fujinon transnasal
scope (5.9 mm in diameter) and was preferred by them to other
scopes with smaller diameters; they also reported signiﬁcantly
higher failure rates in women under 35 years.etic methods.
kI et al [5] Barberani et al [7] Hu [5,6]
tep procedures Anesthesia free Endoscopic guided [5]
Gauze pledgetting [6]
LLD Individualized
Yes Individualized
Nil Nil
l
xymet.
Nil Single (optional)
0.05% epinephrine
. liquid Nil 2% Lido. spray [5]
4% Lido. liquid [6]
Nil 8e10% Lido
Middle Individualized
Nil 1e2
Nil Yes
Fig. 3. A patient is watching his stomach and talking with the endoscopist (C.T. Hu)
during transnasal endoscopy.
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As shown in Table 1, the working channel diameter of all
transnasal endoscopes is 2 mm. The diameter of currently available
biopsy forceps for transnasal endoscopes is 1.8 mm. Walter et al
[14] reported a prospective study on 1335 specimens, showing that
biopsy specimens obtained with small-caliber endoscopes had a
diagnostic performance comparable with those obtained with
conventional endoscopes. Unfortunately, the biopsy success rate
with two-directional transnasal endoscopes was compromised by
small gastric lesions, especially those in the posterior aspect of the
cardia [15].
5. Accuracy
A small-caliber scope has certain advantages as well as disad-
vantages. Compared with the 2.8e3.2-mm channels (biopsy for-
ceps is usually 2.3 mm in size) of a standard upper endoscope, the
2-mm channel of a transnasal endoscope limits suctioning and
lens cleaning. Although the diagnostic accuracy of ultraslim
endoscopy has been a clinical concern, unsedated UT-EGD was
reported to be safe, well tolerated, and accurate in diagnosing
hypopharyngeal cancer and screening esophageal lesions [16]. A
few studies reported that, compared with sedated P-EGD, sedated
and unsedated UT-EGD showed more than 96% diagnostic accu-
racy [17,18].
6. Tolerability
6.1. Acceptance of unsedated endoscope insertion
In eastern countries, P-EGD is usually performed without
sedation. Unsedated P-EGD usually induces a gag reﬂex (also
known as the pharyngeal reﬂex), nausea, and a choking sensation.
The gag reﬂex involves a brisk elevation of the soft palate and
bilateral contraction of the pharyngeal muscles. The transnasal
route induces less stimulation to the tongue base, roof of the
mouth, uvula and soft palate, palatine arches (palatoglossal and
palatopharyngeal arches), and area around the tonsils than to the
peroral route [19]. Conventional P-EGD without sedation causes
“endoscophobia,” which may prevent one from undergoing the
procedure repeatedly. By contrast, a patient can not only watch
the procedure comfortably, but also talk with the endoscopist
during transnasal endoscopy (Fig. 3). Several studies have shown
fewer gagging episodes with a UT-EGD than with transoral small-
caliber or conventional P-EGD [19,20]. In one study, more than
90% of the patients were willing to repeat UT-EGD [21], sug-
gesting that UT-EGD is better tolerated than the conventional EGD
[19,20].
6.2. Cardiovascular tolerance
Cardiovascular tolerance [22] and sympathetic stimulation [23]
were assessed during UT-EGD. Although changes in peripheral
blood oxygen saturation were minimal with either procedure, a
signiﬁcantly lower elevation of blood pressure and pulse rate was
observed in patients undergoing UT-EGD than in those undergoing
P-EGD [24].
6.3. Autonomic nervous system
Mori et al [23] performed a prospective randomized study in
which the blood pressure and pulse rate, as well as autonomic
nervous function, were evaluated during transnasal EGD and
compared with those in oral procedures using the same ultrathinendoscope. They demonstrated a lower sympathetic stimulation in
UT-EGD than in P-EGD, resulting in less elevation of blood pressure
and pulse rate. However, both endoscopic procedures suppressed
parasympathetic activity equally.7. Safety
7.1. Fewer cardiovascular side effects
UT-EGD is safer and less stressful for patients than conventional
P-EGD. It was found to be safer with fewer cardiovascular side ef-
fects than conventional P-EGD [19]. The major problem of con-
ventional P-EGD is intravenous sedation. In one study, a signiﬁcant
increase in heart rate and a decrease in oxygen saturation were
found to occur more frequently in conventional P-EGD than in UT-
EGD [25]. The double product (heart rate systolic blood pressure)
was also increased signiﬁcantly in the conventional P-EGD group
compared with the UT-EGD group [25].7.2. Less autonomic nervous stimulation
The autonomic nervous system is divided into the sympathetic
nervous system and parasympathetic nervous system, which, ac-
cording to a general rule of thumb, are categorized as "excitatory"
and "inhibitory," respectively. UT-EGD has fewer side effects on
cardiopulmonary function [22,25] and the autonomic nervous
system than conventional P-EGD [23], because it requires minimal
or no sedation. Fentanyl and propofol are the two drugs that are
used commonly for intravenous sedation. Both reduce sympa-
thetic tone to a greater extent than parasympathetic tone, thus
decreasing blood pressure and heart rate, and predisposing pa-
tients to parasympathetic responses such as the vagovagal reﬂex.
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Elderly and bedridden patients are prone to aspiration, pneu-
monia, and oxygen desaturation. P-EGD may stimulate salivary
secretion, thus increasing the risk of the above mentioned adverse
events. Yuki et al [26] found that the risk of aspiration pneumonia
was much lower with UT-EGD than with P-EGD in elderly and
bedridden patients. UT-EGD was reported to have less inﬂuence on
oxygen saturation than P-EGD [25]. Similarly, UT-EGDwas reported
to be a safer method than P-EGD in aged hypertensive, critically ill,
and bedridden patients who were undergoing percutaneous
endoscopic gastrostomy feeding [26].
8. Cost effectiveness
Several reports found that UT-EGD requires a signiﬁcantly
shorter procedure and recovery time, with signiﬁcantly lower costs
for recovery rooms, personnel, intravenous access devices, and
oxygen monitors, compared with P-EGD in sedated patients [4,27].
However, the development of UT-EGD has been very slow in some
western countries. One of the reasons for this slow development is
the potential impact of elimination of intravenous sedation charges
from health insurance, which constitute a major source of income
for endoscopists there.
9. Complications
9.1. Insertion injury to the nasal cavity
The major complication associated with UT-EGD is epistaxis,
with reported rates between 0% and 22% [28]. In Japanese studies,
the rates of epistaxis were reported to be in the range of 0e5% and
all epistaxis was mild. However, most of these studies did not
clarify the severity of epistaxis, because there are still no guidelines
to grade nasal bleeding. Mori et al [24] proposed a three-grade scale
for measuring the severity of epistaxis as a complication of trans-
nasal endoscopy. Our group recommended a more solid, unam-
biguous proposal, suggesting that a thorough transnasal endoscopy
report should include “how and where” bleeding was caused [29].
In our study, the following grading scheme was used: grade 1
(mucosal redness), grade 2 (conﬁned hemorrhage inside the nasal
cavity), and grade 3 (unconﬁned bleeding out of the nostril or into
the hypopharynx).
9.2. Insertion injury outside the nasal cavity
Severe complications associated with UT-EGD included one case
of proximal esophageal perforation [30]. The procedure was termi-
nated in a 56-year-old woman with severe gagging, and she was
dischargedhome. Subcutaneous emphysemawas foundafter several
hours, and a small proximal esophageal perforation was diagnosed.
This case should remind endoscopists that during endoscopic
insertion in the soft palate, uvula, hypopharynx, and the upper
esophageal sphincter (cricopharyngeal muscle), severe gagging can
elicit strong contraction; scope insertion should be gentle to avoid
mucosal injury or even upper esophageal perforation.
9.3. Insertion difﬁculty
Endoscopists should avoid forced transnasal insertion through
an extremely narrow nasal tract because it can cause severe nasal
pain, nasomucosal injury, frank epistaxis, andwithdrawal difﬁculty.
When insertion into both nasal cavities is difﬁcult, the same ul-
trathin scope can be inserted transorally with the aid of a smaller
mouth piece.9.4. Withdrawal difﬁculty
Tatsumi et al [31] reported difﬁcult withdrawal of the scope in
0.12% of approximately 13,000 cases treated in 14 Japanese in-
stitutions. Prior to beginning UT-EGD, selecting the most patent
meatus for insertion using a more reliable method (i.e., nasoen-
doscopy) than the subjective sniff test, and using the proper meatus
and insertion angle (i.e., middle nasal meatus-scope perpendicular
to the face) can help prevent this problem. When there is difﬁculty
in withdrawing the scope, the following methods are recom-
mended: (1) rotate the scope slightly; (2) resume the original
insertion angle; (3) add extra 2% lidocaine gel to the scope shaft and
insert the tip into the upper esophagus to lubricate the turbinates,
nasal septum, and lateral wall; and (4) administer another bolus of
decongestive anesthesia to shrink the nasal tract which might have
re-narrowed after initial decongestion.
9.5. Early versus late nasal symptoms
Although several early complications such as epistaxis, sinusitis,
transient lightheadedness, and mucous discharge have been re-
ported by patients, still no studies have emphasized delayed side
effects of the procedure. Our preliminary data showed that some
patients complained of persistent nasal pain for more than 1 week.
Very few patients had the abovementioned nasal complaints for
more than several days. Some patients reported blood clots when
blowing their nose for a few days to 1 week, suggesting insidious
bleeding after the UT-EGD procedure. Endoscopists in western
countries should note these late symptoms and complications,
especially in Asian patients and those with a narrowed nasal cavity.
10. Therapeutic applications
The following indications have emerged for therapeutic UT-
EGD: (1) nasoenteral feeding tube placement; (2) esophageal
dilator placement; (3) positioning of pH and impedance catheters;
(4) percutaneous endoscopic gastrostomy; (5) cholangioscopy and
biliary drainage in septic patients; and (6) transnasal endoscopic
retrograde cholangiopancreatography [32].
11. Other applications
11.1. Manometry
The use of small-caliber esophagoscopy makes possible simul-
taneous manometry and endoscopic observation of the esophagus.
This combination has been proved to be useful in the evaluation of
esophageal peristaltic function, such as in the diagnosis of gastro-
esophageal reﬂux disease [33].
11.2. Narrow band imaging
Olympus NBI improves visibility of the capillaries, veins, and
other subtle tissue structures by placing narrow bandpass ﬁlters in
front of a conventional white-light source. NBI uses two discrete
bands of light: a blue light at 415 nm and a green light at 540 nm.
Narrow-band blue light displays superﬁcial capillary networks,
whereas green light displays subepithelial veins. On the monitor,
capillaries are displayed in brown and veins in cyan. A transnasal
endoscope equipped with NBI and Lugol staining is useful for
screening patients with head and neck cancer, especially thosewith
difﬁculties (such as trismus) receiving P-EGD. The sensitivity of
diagnosing esophageal lesions has increased with nonmagniﬁed
NBI UT-EGD [34].
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Visible light consists of wavelengths from red to purple. Unlike NBI
(which uses optical ﬁlters), Fujinon FICE focuses on a speciﬁc light
spectra. A spectral image, the image captured by a wavelength, of a
speciﬁcwavelength is ampliﬁedelectricallyandreconstructed tocreate
a FICE image. FICEprovides a comparisonof spectral images ofdiseased
and surrounding normal areas for enhancement of the contrast by
combining wavelengths with greater differences in signals [35].11.4. iSCAN technology
The Pentax iSCAN consists of three types of image enhance-
ment: surface enhancement (enhancement of the structure
through recognition of the edges), contrast enhancementFig. 4. A sample transnasal endoscopy report. CLO ¼ Campylobacter-like organism; GEJ ¼ es
P.O. ¼ per os (orally).(enhancement of depressed areas and differences in structure
through colored presentation of low-density areas), and tone
enhancement (enhancement tailored to individual organs through
modiﬁcation of the combination of the red/green/blue components
for each pixel). NBI is usually much darker than conventional
white-light images, but iSCAN images are as bright as conventional
white-light images. Therefore, observation of much larger areas in a
distant view is possible with iSCAN, compared with NBI.12. Remaining problems
UT-EGD has been applied in various gastrointestinal therapeutic
procedures such as esophageal manometry, nasoenteric feeding
tube placement, percutaneous endoscopic gastrostomy, endoscopic
retrograde cholangiopancreatography with nasobiliary drainage,ophagogastric junction; I.M. ¼ intramuscular injection; LA ¼ Los Angeles classiﬁcation;
C.-T. Hu / Tzu Chi Medical Journal 25 (2013) 139e145 145and long intestinal tube placement in small bowel obstruction.
However, the following issues still remain: (1) there is still no
consensus on issues of informed consent, nasal anesthesia, inser-
tion, and exertion; (ii) indications and contraindications are not yet
standardized [36]; and (3) hemoclipping for gastrointestinal
bleeding and band ligation for varices ligation are not yet applicable.
Above all, UT-EGD should not be regarded as a simple procedure. It
involves much training for an endoscopist, including the one who
has been trained well in P-EGD. We provide a sample transnasal
endoscopy report in Fig. 4, which reveals clinical aspects and situ-
ations that should be considered and recorded by endoscopists.
In conclusion, transnasal endoscopy is an important milestone
in gastrointestinal diagnostic and therapeutic endoscopy. Selection
of the most patent meatus, methods of nasal anesthesia, and
endoscope insertion/exertion techniques are learning issues for
gastrointestinal endoscopists who want to become experienced in
this procedure. UT-EGD is a useful supplement to conventional P-
EGD in a variety of situations because it is well tolerated by patients.
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